Division of Women's Health Internal Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA.
Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Breast Cancer. 2022 Jan;29(1):19-29. doi: 10.1007/s12282-021-01298-x. Epub 2021 Oct 19.
Breast cancer (BC) is the second most common cancer in women, affecting 1 in 8 women in the United States (12.5%) in their lifetime. However, some women have a higher lifetime risk of BC because of genetic and lifestyle factors, mammographic breast density, and reproductive and hormonal factors. Because BC risk is variable, screening and prevention strategies should be individualized after considering patient-specific risk factors. Thus, health care professionals need to be able to assess risk profiles, identify high-risk women, and individualize screening and prevention strategies through a shared decision-making process. In this article, we review the risk factors for BC, risk-assessment models that identify high-risk patients, and preventive medications and lifestyle modifications that may decrease risk. We also discuss the benefits and limitations of various supplemental screening methods.
乳腺癌(BC)是女性中第二常见的癌症,在美国,每 8 名女性中就有 1 人(12.5%)一生中会患乳腺癌。然而,由于遗传和生活方式因素、乳腺 X 线照相术乳房密度以及生殖和激素因素,一些女性有更高的乳腺癌终生风险。由于乳腺癌风险是可变的,因此在考虑患者特定的风险因素后,应个体化考虑筛查和预防策略。因此,医疗保健专业人员需要能够通过共同决策过程评估风险概况,识别高危女性,并个体化筛查和预防策略。在本文中,我们回顾了乳腺癌的危险因素、可识别高危患者的风险评估模型,以及可能降低风险的预防性药物和生活方式改变。我们还讨论了各种补充筛查方法的优缺点。